
Biodesix BDSX
€ 14.21
2.48%
Quartalsbericht 2026-Q1
hinzugefügt 23.05.2026
Biodesix Langfristiger Schuldenstrom 2011-2026 | BDSX
Langfristiger Schuldenstrom Jährlich Biodesix
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.36 M | 719 K | 252 K | 1.54 M | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.54 M | 252 K | 970 K |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
1.46 M | $ 19.5 | 7.5 % | $ 600 M | ||
|
Celcuity
CELC
|
54 K | $ 92.47 | 3.96 % | $ 4.32 B | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
662 K | $ 5.76 | 11.41 % | $ 7.66 M | ||
|
Castle Biosciences
CSTL
|
1.32 M | $ 21.6 | 5.93 % | $ 626 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
535 K | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
27.7 M | $ 133.06 | 4.75 % | $ 16.7 B | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
36.3 M | $ 152.8 | 6.18 % | $ 12 B | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 23.12 | 3.63 % | $ 1.23 B | ||
|
Illumina
ILMN
|
78 M | $ 168.06 | -1.68 % | $ 26 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 1.79 | 2.29 % | $ 7.92 M | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
209 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Mettler-Toledo International
MTD
|
35.1 M | - | - | $ 24.3 B | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | - | - | $ 6.94 B | ||
|
NeoGenomics
NEO
|
4.78 M | $ 11.31 | 11.54 % | $ 1.45 B | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 185.79 | 3.29 % | $ 9.21 B | ||
|
Natera
NTRA
|
15.6 M | $ 222.1 | 4.84 % | $ 30.4 B | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 458.69 | 1.75 % | $ 13.2 B | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
451 K | $ 19.75 | 3.73 % | $ 442 M | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.69 | 6.59 % | $ 434 M | ||
|
Personalis
PSNL
|
6.89 M | $ 12.1 | 12.24 % | $ 1.08 B | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 25.99 | 2.52 % | $ 24.6 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 7.01 | 4.32 % | $ 293 M | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
726 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
358 K | - | - | $ 4.94 M | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 260.97 | 0.79 % | $ 21.7 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | - | - | $ 4.42 B | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 482.03 | 1.7 % | $ 182 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.12 | 3.52 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 196.12 | 1.27 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | ||
|
Waters Corporation
WAT
|
31.1 M | $ 376.47 | -0.87 % | $ 22.4 B |